There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

Cases of secondary tumors have been reported as a possible adverse reaction to the treatment of certain blood cancers with CAR T-cells. A recent analysis of the cases reported to the ...

If you claim your product is the best, the easiest, or the most advanced, you need to provide specific reasons why. An example of this product-writing technique can be seen in the product description ...

The rapid advancements in regenerative medicine (RM), including cell therapies, gene therapies, tissue-engineered products, and combined RM advanced therapies, require the development of regulatory ...

The Cell and Gene Therapy Catapult (CGT Catapult) presented the data in its UK 2024 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database. The UK maintained its position as a highly ...

Results of a recent study provided insight into the training needs of nurses involved in the use of advanced therapy medicinal products (ATMPs). The findings were reported in the journal Clinical ...

It may be, she added, that weekly therapy sessions are simply not scalable to a broad population, and the field should explore light-touch alternatives, like single-session interventions and ...

The Massachusetts company plans to launch its registrational trial, named exPDite-2, in the first half of 2025 following discussions with the US Food and Drug Administration (FDA) after the therapy ...

Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India ...

aBerlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité–Universitätsmedizin Berlin, Berlin, Germany bBerlin Center for Advanced Therapies (BeCAT), Charité–Universitätsmedizin Berlin, ...